Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Atara Biotherapeutics (AT20) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:AT20Atara BiotherapeuticsEUR 7.10EUR 75.80M-7.71-31.73%Moderate BuyUnlock the DE:AT20 analyst price target with TipRanks PremiumDE:AT20Unlock the DE:AT20 top-analyst price target with TipRanks Premium
MGNXMacroGenics$2.29$147.78M-10.4155.78%Moderate BuyUnlock the MGNX analyst price target with TipRanks PremiumDE:AT20 vs MGNXUnlock the MGNX top-analyst price target with TipRanks Premium
ZNTLZentalis Pharmaceuticals$1.68$185.72M-0.8625.37%Moderate BuyUnlock the ZNTL analyst price target with TipRanks PremiumDE:AT20 vs ZNTLUnlock the ZNTL top-analyst price target with TipRanks Premium
SRZNSurrozen$31.67$607.69M-0.72144.74%Strong BuyUnlock the SRZN analyst price target with TipRanks PremiumDE:AT20 vs SRZNUnlock the SRZN top-analyst price target with TipRanks Premium
TCRXTScan Therapeutics$0.17$12.58M-0.19-85.88%HoldUnlock the TCRX analyst price target with TipRanks PremiumDE:AT20 vs TCRXUnlock the TCRX top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:AT20Atara Biotherapeutics7.10-4.10-36.61%
MGNXMacroGenics2.290.7952.67%
ZNTLZentalis Pharmaceuticals1.680.3526.32%
SRZNSurrozen31.6718.69143.99%
TCRXTScan Therapeutics0.17-0.93-84.73%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts